These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8835752)

  • 21. Terbinafine-induced subacute cutaneous lupus erythematosus.
    McKay DA; Schofield OM; Benton EC
    Acta Derm Venereol; 2004; 84(6):472-4. PubMed ID: 15844640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial.
    Drake LA; Shear NH; Arlette JP; Cloutier R; Danby FW; Elewski BE; Garnis-Jones S; Giroux JM; Gratton D; Gulliver W; Hull P; Jones HE; Journet M; Krol AL; Leyden JJ; Maddin SC; Ross JB; Savin RC; Scher RK; Sibbald GR; Tawfik NH; Zaias N; Tolpin M; Evans S; Birnbaum JE
    J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):740-5. PubMed ID: 9366820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ursodeoxycholic acid for terbinafine-induced toxic hepatitis.
    Agca E; Akcay A; Simsek H
    Ann Pharmacother; 2004 Jun; 38(6):1088-9. PubMed ID: 15122001
    [No Abstract]   [Full Text] [Related]  

  • 24. [Oral terbinafine-induced plantar pustular psoriasis].
    Le Guyadec T; Saint-Blancard P; Bosonnet S; Le Vagueresse R; Lanternier G
    Ann Dermatol Venereol; 2000 Mar; 127(3):279-81. PubMed ID: 10804301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutropenia and pancytopenia associated with oral terbinafine.
    Kovacs MJ; Alshammari S; Guenther L; Bourcier M
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):806. PubMed ID: 7929931
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
    Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
    Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis associated with terbinafine therapy: three case reports and a review of the literature.
    Gupta AK; del Rosso JQ; Lynde CW; Brown GH; Shear NH
    Clin Exp Dermatol; 1998 Mar; 23(2):64-7. PubMed ID: 9692307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Terbinafine and cholestatic hepatitis].
    Tejada García M; Llvona Hevia AM; Martín Arias L; García-Pando AC
    Med Clin (Barc); 1997 Sep; 109(9):356. PubMed ID: 9379769
    [No Abstract]   [Full Text] [Related]  

  • 29. Terbinafine versus itraconazole: a controlled clinical comparison in onychomycosis of the toenails.
    Bräutigam M
    J Am Acad Dermatol; 1998 May; 38(5 Pt 3):S53-6. PubMed ID: 9594938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe neutropenia associated with oral terbinafine therapy.
    Gupta AK; Soori GS; Del Rosso JQ; Bartos PB; Shear NH
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):765-7. PubMed ID: 9591825
    [No Abstract]   [Full Text] [Related]  

  • 31. Inverse psoriasis induced by terbinafine.
    Pauluzzi P; Boccucci N
    Acta Derm Venereol; 1999 Sep; 79(5):389. PubMed ID: 10494721
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiple onychocryptosis following treatment of onychomycosis with oral terbinafine.
    Weaver TD; Jespersen DL
    Cutis; 2000 Sep; 66(3):211-2. PubMed ID: 11006857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Terbinafine-associated hepatotoxicity.
    Ajit C; Suvannasankha A; Zaeri N; Munoz SJ
    Am J Med Sci; 2003 May; 325(5):292-5. PubMed ID: 12792250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acute hepatitis related to the ingestion of terbinafine].
    Vantaux P; Grasset D; Nougue J; Lagier E; Seigneuric C
    Gastroenterol Clin Biol; 1996; 20(4):402-3. PubMed ID: 8758509
    [No Abstract]   [Full Text] [Related]  

  • 35. Systematic review of severe acute liver injury caused by terbinafine.
    Yan J; Wang X; Chen S
    Int J Clin Pharm; 2014 Aug; 36(4):679-83. PubMed ID: 24986266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Terbinafine-induced subacute cutaneous lupus erythematosus.
    Brooke R; Coulson IH; al-Dawoud A
    Br J Dermatol; 1998 Dec; 139(6):1132-3. PubMed ID: 9990400
    [No Abstract]   [Full Text] [Related]  

  • 37. Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US.
    Van Duyn Graham L; Elewski BE
    Mycoses; 2011 Nov; 54(6):e679-85. PubMed ID: 21668517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histologic changes resembling acute rejection in a liver transplant patient treated with terbinafine.
    Lovell MO; Speeg KV; Havranek RD; Sharkey FE
    Hum Pathol; 2003 Feb; 34(2):187-9. PubMed ID: 12612888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral corticosteroids did not prevent AGEP due to terbinafine.
    Bajaj V; Simpson N
    Acta Derm Venereol; 2006; 86(5):448-9. PubMed ID: 16955194
    [No Abstract]   [Full Text] [Related]  

  • 40. Terbinafine: an update.
    Gupta AK; Shear NH
    J Am Acad Dermatol; 1997 Dec; 37(6):979-88. PubMed ID: 9418768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.